相关实验视频
Updated: Jun 20, 2025

09:19
Isolating Nasal Olfactory Stem Cells from Rodents or Humans
Published on: August 22, 2011
30.7K
来自老鼠鼻腔粘膜的外皮介质干细胞:慢性鼻炎的新疗法
Liujin Li1, ZhaoHui Liu1, ChunLin Zhang1
1Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Immunity, inflammation and disease
|July 18, 2024
概括
鼻腔粘膜衍生的外皮介质干细胞 (NM-EMSCs) 降低了患有慢性鼻炎 (CRS) 的老鼠的炎症. 这些干细胞通过减轻鼻腔粘膜中的炎症反应,为CRS提供了潜在的治疗方法.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 慢性鼻炎 (CRS) 是一种影响鼻腔粘膜的普遍炎症状况.
- 目前对CRS的治疗可能存在局限性,需要探索新的治疗策略.
研究的目的:
- 在慢性鼻炎 (CRS) 的老鼠模型中研究鼻粘膜衍生的外皮介质干细胞 (NM-EMSCs) 的治疗潜力.
- 阐明NM-EMSCs调节CRS中的炎症状态的潜在机制.
主要方法:
- 从Sprague-Dawley大鼠中分离和描述NM-EMSCs.
- 通过局部鼻腔粘膜注射建立CRS的老鼠模型.
- 在CRS模型大鼠的鼻腔粘膜中注射NM-EMSC或盐水.
- 在注射后的不同时间点对鼻腔粘膜组织进行组织学分析 (HE,马森三色,PAS染色).
主要成果:
- 孤立的NM-EMSCs表达了特征标记物 (CD73,CD105,CD90) 并表现出多效.
- 在CRS模型大鼠中,鼻腔粘膜显著加厚,炎症细胞透,原蛋白和粘素沉积增加.
- 随着时间的推移,NM-EMSC治疗逐渐缓解了鼻腔粘膜的加厚,减少了炎症细胞的透,并减少了原蛋白和粘素的分布.
结论:
- 鼻腔粘膜衍生的外皮介质干细胞 (NM-EMSCs) 在慢性鼻炎的老鼠模型中显示出显著的抗炎作用.
- 通过减轻鼻膜炎症,NM-EMSCs作为一种新型治疗剂来管理CRS具有前景.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K

